Ironwood Pharma (IRWD) Highlights 2015 Accomplishments; Offers Five-Year Operating Goals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St on track for subdued September start as high yields, oil prices dent sentiment
- Oil up more than 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Ironwood Pharmaceuticals Details Strategy to Build Top-Performing Commercial Biotechnology Company
January 11, 2016 9:01 AM EST- At least $1 billion in LINZESS® (linaclotide) annual net sales expected by 2020; greater than $2 billion linaclotide U.S. peak sales potential -
- At least three additional blockbuster opportunities expected to be in later-stage development by 2017/2018 -
- Financial strength to manage core business without raising additional capital -
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood... More
